Gemcitabine plus cisplatin versus fluorouracil plus cisplatin as a first-line concurrent chemotherapy regimen in nasopharyngeal carcinoma: a prospective, multi-institution, randomized controlled phase II study.

Xiang-Yun KongJian-Xun LuXin-Wen YuJian ZhangQian-Lan XuRong-Jun ZhangJing-Lin MiShu-Fang LiaoJin-Fang FanXiao-Li QinDa-Cheng YaoHua-Ying TangWei Jiang

Published in: Cancer chemotherapy and pharmacology (2019)

Gemcitabine plus cisplatin could be used as an alternative regimen in CCRT for nasopharyngeal carcinoma.

Keyphrases

locally advanced
phase ii study
rectal cancer
squamous cell carcinoma
open label
radiation therapy
placebo controlled
double blind
clinical trial
phase iii
phase ii
study protocol